Omega-3 and Aspirin in Periodontal Regeneration

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the efficacy of systemic administration of omega 3 PUFA plus low dose aspirin as an adjunctive therapy to regenerative modality of grade II furcation defects in periodontitis patients.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: October 6 University
• Collaborator: Cairo University
• Treatments: Aspirin

Criteria

Inclusion Criteria:

• suffering moderate to sever chronic periodontitis and displaying at least a single grade II furcation defect according to Glickman's classification 1953, determined by both clinical and radiographic examinations;

• free from systemic diseases known to influence the periodontal condition and not receiving any medication known to affect the periodontal status;

• have not receive any periodontal therapy for a minimum of 6 months prior to the study.

Exclusion Criteria:

• Known hypersensitivity or allergy to one of the used medications

• Pregnancy or lactation

• Heavy smoking (more than 10cigarretes/day)

• History of alcohol abuse

• Participation in other clinical trials